The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of JS001, a monoclonal antibody targeting programed death-1 (PD-1), on responses and disease control in patients with advanced or refractory alveolar soft part sarcoma: Results from a phase 1 trial.
 
Sheng Yang
No Relationships to Disclose
 
Jianliang Yang
No Relationships to Disclose
 
Xiaohong Han
No Relationships to Disclose
 
Ying Han
No Relationships to Disclose
 
Shiyu Jiang
No Relationships to Disclose
 
Jiarui Yao
No Relationships to Disclose
 
Zhishang Zhang
No Relationships to Disclose
 
Shuxiang Zhang
No Relationships to Disclose
 
Peng Liu
No Relationships to Disclose
 
Yan Qin
No Relationships to Disclose
 
Hui Feng
Employment - Shanghai Junshi BioSciences
Leadership - Shanghai Junshi BioSciences
Stock and Other Ownership Interests - Shanghai Junshi BioSciences
Patents, Royalties, Other Intellectual Property - Shanghai Junshi BioSciences (Inst)
 
Sheng Yao
Employment - Shanghai Junshi BioSciences
Leadership - Shanghai Junshi BioSciences
Stock and Other Ownership Interests - Shanghai Junshi BioSciences
Patents, Royalties, Other Intellectual Property - Shanghai Junshi BioSciences (Inst)
 
Yan Sun
No Relationships to Disclose
 
Yuankai Shi
No Relationships to Disclose